China’s pharmaceutical sector is rapidly moving into the global weight loss drug race after the expiration of Novo Nordisk’s semaglutide patent in the country, unlocking a major commercial opportunity for domestic developers. The shift comes as demand for obesity treatments surges worldwide and
China’s leading lidar manufacturers are accelerating their transition into robotics, signaling a strategic pivot as the country strengthens its position in the global supply chain for next generation automation technologies. Hesai Group and RoboSense Technology, both major players in automotive sensing systems, are
US researchers and agritech companies are intensifying efforts to revive the struggling wheat sector by developing hybrid and genetically modified seeds designed to boost yields and improve resilience against climate stress. Scientists are experimenting with advanced genetic traits, including drought resistance, as the
Gilead Sciences has agreed to acquire US based biotech firm Ouro Medicines in a deal valued at up to 2.18 billion dollars, gaining access to a promising antibody based treatment originally licensed from China’s Keymed Biosciences. The transaction highlights the growing importance of
Inside a high intensity robotics laboratory in Beijing, engineers are subjecting humanoid robots to rigorous endurance testing as China accelerates efforts to bring advanced robotics into real world environments. The facility operated by X Humanoid focuses on preparing machines for unpredictable human settings,
China’s Unitree Robotics has moved forward with plans for an initial public offering on Shanghai’s Star Market, aiming to raise about 4.2 billion yuan as interest grows around humanoid robotics and embodied artificial intelligence. The listing is being closely watched by investors and
A prominent life scientist with deep ties to US research institutions has shifted his academic base to China, highlighting a growing trend of talent movement in global science. Shu Xiaokun, known for his work in advanced biological imaging and molecular tools, has returned
Major international pharmaceutical companies are accelerating their expansion in China, signaling a strategic shift toward localized production as global supply chains become more fragmented. AstraZeneca has announced plans to establish new drug manufacturing facilities in Guangzhou and Shanghai, alongside a dedicated innovation centre
China’s robotics sector is entering a new phase as Unitree Robotics moves toward a major public listing, aiming to raise around 4.2 billion yuan or roughly 610 million dollars on Shanghai’s Star Market. The Hangzhou based company has quickly emerged as one of
China’s rapid progress in robotics has captured global attention, with advanced humanoid machines taking centre stage in high profile events and demonstrations. Performances featuring coordinated movements and complex routines have highlighted the country’s growing capabilities in embodied intelligence, where artificial intelligence is integrated
